RUNX1 is a frequently mutated gene that, in the absence of other recurrent genetic alterations or AML-MRC criteria, defined a provisional entity in WHO17 (from now on AML-RUNX1m). The gene discussed is RUNX1; the disease is acute myeloid leukemia.